Ovarian Dysgerminoma
2 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Changes in Brain Function in Patients With Stage I, Stage II, Stage III, or Stage IV Ovarian, Primary Peritoneal, or Fallopian Tube Cancer Who Are Receiving Chemotherapy (NCT01080521) | Gynecologic Oncology Group | 2010-04-01 |
| Imatinib Mesylate in Treating Patients With Progressive, Refractory, or Recurrent Stage II or Stage III Testicular or Ovarian Cancer (NCT00042952) | National Cancer Institute (NCI) | 2002-06-01 |
Track Ovarian Dysgerminoma automatically
Every clearance here is in the API, with alerts when new ones post.